CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating expenses:
Selling, general and administrative	$ 1,933	$ 3,044	$ 8,316	$ 11,014
Research and development	597	972	2,485	11,144
Change in fair value of contingent consideration	(37)	0	(3,509)	(97,464)
Total operating costs and expenses	2,493	4,016	7,292	(75,306)
(Loss) income from operations	(2,493)	(4,016)	(7,292)	75,306
Other (loss) income:
Change in fair value of convertible notes	(1,877)	(1,878)	(5,362)	(170)
Change in fair value of warrants	(236)	(377)	85,950	(15,376)
Loss on issuance of warrants			(75,644)
Loss on embedded forward purchase agreements and derivative liabilities, net		81		(19,931)
Other income, net	68	19	263	94
Total other (loss) income, net	(2,045)	(2,155)	5,207	(35,383)
(Loss) income before taxes	(4,538)	(6,171)	(2,085)	39,923
Net (loss) income	$ (4,538)	$ (6,171)	$ (2,085)	$ 39,923
Basic net (loss) income per share (in dollars per share)	$ (0.39)	$ (11.24)	$ (0.23)	$ 74.53
Diluted net (loss) income per share (in dollars per share)	$ (0.39)	$ (11.24)	$ (0.23)	$ 69.53
Weighted average shares of common stock outstanding used to compute basic net (loss) income per share	11,634,946	549,175	8,931,566	535,693
Weighted average shares of common stock outstanding used to compute diluted net (loss) income per share	11,634,946	549,175	8,931,566	574,216